Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital
Alice Ramos Oliveira Silva, Diamantino Salgado, Luís Phillipe Nagem Lopes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Bacterial Coinfection and Antibiotic Resistance Profiles among Hospitalised COVID-19 Patients
Abdulrahman S. Bazaid, Heba Barnawi, Husam Qanash, et al.
Microorganisms (2022) Vol. 10, Iss. 3, pp. 495-495
Open Access | Times Cited: 71
Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic
Genara Romero Thomas, Alejandra Corso, Fernando Pasterán, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 11, pp. 1-8
Open Access | Times Cited: 65
Effect of the COVID-19 pandemic on antibiotic consumption: A systematic review comparing 2019 and 2020 data
Mizuho Fukushige, Nhat-Hoang Ngo, Donny Lukmanto, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 42
RETRACTED: Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
Mohammed Kanan Alshammari, Maali Ramadan, Hanan Haif, et al.
Antibiotics (2023) Vol. 12, Iss. 10, pp. 1504-1504
Open Access | Times Cited: 27
First Outbreak of NDM-1-Producing Klebsiella pneumoniae ST11 in a Portuguese Hospital Centre during the COVID-19 Pandemic
Gabriel Mendes, João F. Ramalho, Aida Duarte, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 251-251
Open Access | Times Cited: 29
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Decoding Urinary Tract Infection Trends: A 5-Year Snapshot from Central Portugal
Francisco Rodrigues, Patrícia Coelho, Sónia Mateus, et al.
Clinics and Practice (2025) Vol. 15, Iss. 1, pp. 14-14
Open Access
Antibiotic Utilization and Resistance According to the WHO AWaRe Classification in Intensive Care Units After COVID-19 Third Wave in Pakistan: Findings and Implications
Muhammad Shahid Iqbal, Mohd Faiyaz Khan, Sadaf Farooqui, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 481-481
Open Access
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland
Olivier Friedli, Michael Gasser, Alexia Cusini, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 792-792
Open Access | Times Cited: 22
Genomic surveillance of carbapenem-resistant Klebsiella pneumoniae reveals a prolonged outbreak of extensively drug-resistant ST147 NDM-1 during the COVID-19 pandemic in the Apulia region (Southern Italy)
Daniela Loconsole, Anna Sallustio, Davide Sacco, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 36, pp. 260-266
Open Access | Times Cited: 4
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials
Nathália Mariana Santos Sansone, Matheus Negri Boschiero, Fernando Augusto Lima Marson
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2206-2206
Open Access | Times Cited: 4
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
Francesca Serapide, Angela Quirino, Vincenzo Scaglione, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 957-957
Open Access | Times Cited: 20
Decreased Antibiotic Consumption Coincided with Reduction in Bacteremia Caused by Bacterial Species with Respiratory Transmission Potential during the COVID-19 Pandemic
Vincent Chi‐Chung Cheng, Shuk‐Ching Wong, Simon Yung-Chun So, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 746-746
Open Access | Times Cited: 20
Global Coinfections with Bacteria, Fungi, and Respiratory Viruses in Children with SARS-CoV-2: A Systematic Review and Meta-Analysis
Saad Alhumaid, Muneera Alabdulqader, Nourah Al Dossary, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 11, pp. 380-380
Open Access | Times Cited: 19
Photodegradation of ceftriaxone using g-C3N4-ZnO nanocomposite as an efficient photocatalyst
Karina Portillo-Cortez, Josué E. Romero‐Ibarra, D. Domínguez, et al.
Journal of Photochemistry and Photobiology A Chemistry (2023) Vol. 445, pp. 115090-115090
Closed Access | Times Cited: 9
Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance
Melanie Betchen, Holly M. Giovinco, Michael Curry, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 614-614
Open Access | Times Cited: 15
Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients
Bianca Brandão de Paula Antunes, Amanda De Araújo Batista Da Silva, Patrícia Helena Castro Nunes, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 3, pp. 840-849
Open Access | Times Cited: 8
The impact of the COVID‐19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland
Mamoon A. Aldeyab, William Crowe, Reema Karasneh, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 9, pp. 2851-2866
Open Access | Times Cited: 8
How can we tackle the overuse of antibiotics in low- and middle-income countries?
Giorgia Sulis, Sena Sayood, Sumanth Gandra
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 11, pp. 1189-1201
Closed Access | Times Cited: 8
Metal-Organic Frameworks for Wastewater Decontamination: Discovering Intellectual Structure and Research Trends
Muhammad Nihal Naseer, Juhana Jaafar, Hazlina Junoh, et al.
Materials (2022) Vol. 15, Iss. 14, pp. 5053-5053
Open Access | Times Cited: 12
Antibiotic Consumption and Deviation of Prescribed Daily Dose From the Defined Daily Dose in Critical Care Patients: A Point-Prevalence Study
Patrícia Helena Castro Nunes, Jéssica Pronestino de Lima Moreira, Alessandra de Figueiredo Thompson, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
How Structure–Function Relationships of 1,4‐Naphthoquinones Combat Antimicrobial Resistance in Multidrug‐Resistant (MDR) Pathogens
Nishigandha Mone, Sahil Syed, Palanisamy Ravichandiran, et al.
ChemMedChem (2022) Vol. 18, Iss. 2
Closed Access | Times Cited: 11
Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018–2021
Twisha S Patel, Olivia L. McGovern, Garrett Mahon, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_1, pp. S4-S11
Open Access | Times Cited: 5
Carbapenem use correlates with percentage of patients with COVID-19 in intensive care units
Salma AlBahrani, Feras Almogbel, Wafa Alanazi, et al.
Infection (2022) Vol. 51, Iss. 2, pp. 331-336
Open Access | Times Cited: 7
Plethora of Antibiotics Usage and Evaluation of Carbapenem Prescribing Pattern in Intensive Care Units: A Single-Center Experience of Malaysian Academic Hospital
Chee Lan Lau, Petrick Periyasamy, Muhd Nordin Saud, et al.
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1172-1172
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top